tag:blogger.com,1999:blog-1757651542638337360.post7869762524986158229..comments2024-03-28T07:18:54.855-04:00Comments on Sherry Brescia's Blog: A silent killer that’s on the riseSherry Bresciahttp://www.blogger.com/profile/08015907507443706139noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-1757651542638337360.post-58072627995998086722017-11-16T08:55:11.948-05:002017-11-16T08:55:11.948-05:00Global nonalcoholic steatohepatitis (NASH) treatme...Global nonalcoholic steatohepatitis (NASH) treatment market by phase III drugs in pipeline (Obeticholic Acid, Aramchol, Saroglitazar, and Elafibranor) is estimated to cross $19 Billion in 2025, expanding at a CAGR of 10.0% from 2017 to 2025, published by iHealthcareAnalyst, Inc. <br />https://www.ihealthcareanalyst.com/report/nonalcoholic-steatohepatitis-treatment-market/ Ana Aitawahttps://www.blogger.com/profile/14434902994624457900noreply@blogger.com